GLP–1s: A Healthcare Revolution?

One of this century’s biggest game-changers will likely be a novel drug class that’s showing unprecedented success, or the promise of it, in treating some of the world’s most prevalent conditions.

GLP-1s: A Healthcare Revolution? IpsosThe age of GLP-1s is upon us, with the potential to transform healthcare as we know it. What began as a treatment for type 2 diabetes has expanded to reinvent obesity management – and the promise of this drug class extends far beyond these two diseases for which it is currently approved. 

In this paper, we highlight the impact of GLP-1s to date, and discuss ongoing research suggesting their game-changing potential in combating some of the world's most prevalent and devastating conditions – both within and outside the metabolic arena. We also consider the implications for future healthcare delivery, cost reduction, and the pharmaceutical industry.

Ultimately, we look into a future where millions of lives could potentially be transformed, healthcare burdens dramatically reduced, and new frontiers of treatment unlocked.

The future of medicine is here, and it is led by the GLP-1s.

Download the full paper

Download

The author(s)

More insights about Health

Related news

  • KEYS: Our World in Motion
    E mobility Webinar

    [Webinar] KEYS: Our World in Motion

    At our next KEYS webinar, we’ll be launching the inaugural Ipsos Mobility Report.
  • [Webinar] Real evidence from real experiences: Patient Centric Evidence
    Healthcare Webinar

    [Webinar] Real evidence from real experiences: Patient Centric Evidence

    Regulators, payers and clinicians are asking for more than traditional real world evidence (RWE). They want to understand how treatments affect people’s daily lives - not just what is written in the case report form. But how can you build patient-centric evidence that stands up to scientific, regulatory and commercial scrutiny?
  • Battle For Attention - KEYS Webinar from Ipsos
    Communications Events replay

    [Webinar] KEYS: Battle For Attention

    In today’s hyper-fragmented landscape, communicating using short-form content and social media platforms is an essential part of our toolkit. But are they better suited to short-term engagement rather than long-term brand building? And what does genuinely innovative and creative advertising look like these days?